| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15,000 | $87,900 | $5.86 | 24 Jun 2025 | Direct |
| Minerva Neurosciences, Inc. | Director | Stock Option (right to buy) | 50,000 | 22 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | 22 Dec 2025 | 1 | $0 | 4 | Director | 23 Dec 2025, 16:15 |
| GANX | Gain Therapeutics, Inc. | 24 Jun 2025 | 1 | $0 | 4 | Director | 25 Jun 2025, 17:30 |
| NERV | Minerva Neurosciences, Inc. | 05 Dec 2024 | 1 | $0 | 4 | Director | 06 Dec 2024, 17:45 |
| GANX | Gain Therapeutics, Inc. | 24 Jun 2024 | 1 | $0 | 4 | Director | 26 Jun 2024, 21:30 |
| NERV | Minerva Neurosciences, Inc. | 27 Sep 2023 | 1 | $0 | 4 | Director | 29 Sep 2023, 10:00 |
| GANX | Gain Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:36 |
| GANX | Gain Therapeutics, Inc. | 20 Sep 2022 | 1 | $0 | 4 | Director | 22 Sep 2022, 16:07 |
| NERV | Minerva Neurosciences, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 28 Jun 2022, 19:34 |
| NERV | Minerva Neurosciences, Inc. | 11 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:36 |